Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis
Year: 2019
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: Suma Babu, Eric A. Macklin, Katherine E. Jackson, Elizabeth Simpson, Katy Mahoney, Hong Yu, Jason Walker, Zachary Simmons, William S. David, Paul E. Barkhaus, Laura Simionescu, Mazen M. Dimachkie, Alan Pestronk, Johnny S. Salameh, Michael D. Weiss, Benjamin Rix Brooks, David Schoenfeld, Jeremy Shefner, Swati Aggarwal, Merit E. Cudkowicz, Nazem Atassi
Institutions: Massachusetts General Hospital, Harvard University, Maryland Department of Health, Pennsylvania State University, Penn State Milton S. Hershey Medical Center, Medical College of Wisconsin, SUNY Upstate Medical University, University of Kansas Medical Center, Washington University in St. Louis, American University of Beirut Medical Center, University of Washington Medical Center, Carolinas Medical Center, Barrow Neurological Institute, University of Arizona College of Medicine- Phoenix
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2980051730